Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
Inzucchi SE, Peixoto AJ, Testani JM. Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes. New England Journal Of Medicine 2021, 385: 669-672. PMID: 34379938, DOI: 10.1056/nejmc2107340.Commentaries, Editorials and LettersMeSH KeywordsCardiovascular DiseasesDiabetes Mellitus, Type 2GlucoseHeart Disease Risk FactorsHumansHypoglycemic AgentsPharmaceutical PreparationsRisk Factors